How My 2025 Predictions Went – and Some Predictions for 2026
While America Watched the Border, the Cyber Front Exploded
Let’s All Hope 2026 Brings Us Some Real ‘News’ Outlets
If Elected CA Governor, Eric Swalwell Vows to Weaponize Government Against ICE Agents
'Just Fine:' WI Governor Tony Evers Continues to Withhold SNAP Data From the...
With Islam on the Rise, Gay European Voters Shift to the Right
Yeah, Culture Does Matter
Obamacare Was, Is and Will Always Be a Problem
Oligarchies, Terrorism, Greed, and Other Obstacles to Forecasting the Future
Minnesota’s Fraud Is Blowing the Lid Off a Broken Election System
The Danger of Nick Fuentes' Ideology
Will the US Senate Stall Much-Needed Permitting Reforms?
Video of Woman Saying 'Fraud Is Bad' Fuels Scrutiny of Minnesota Childcare Program
Former Real Estate Professional Convicted in $2.4M Investor Fraud Scheme
New Media Shine While Legacy Media Die
Tipsheet

Rapid Response Test Was Just Approved for the Wuhan Coronavirus

AP Photo/Ted S. Warren

The United States Food and Drug Administration (FDA) on Friday announced that the agency approved the first of its kind rapid response test to detect the Wuhan coronavirus. The agency used an emergency use authorization to fast-track the test's approval. According to the FDA, the test's results are produced roughly 45 minutes after the test is administered. 

Advertisement

The company producing the tests, Cepheid, said the test was designed so that the tests could be used in the 5,000 GeneXpert testing systems throughout the country. This means hospitals could receive results at the point-of-care. These systems are automated, do not require specific training and are capable of running 24/7, something hospitals across the nation already do.

"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," Dr. David Persing, MD, Ph.D., Chief Medical and Technology Officer at Cepheid said in a statement. "An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources."

Cepid said the tests will begin shipping next week.

Although these test will be readily available, Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases, said asymptomatic people should not be tested for the Wuhan coronavirus. Doing so puts health care workers at greater risk because of the lack of personal protective equipment [PPE].

Advertisement

Related:

CORONAVIRUS FDA

"Let me tell you about one of the unintended consequences of individuals who don't need to get tested flood the desire to get tested. Currently, and I hope we will be able to change it, and make it much less reliable, PPEs," he explained during Saturday's press conference. "When you go in and get tested, you are consuming personal protective equipment: masks and gowns. Those are high priority for the health care workers who are taking care of people who have coronavirus disease."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement